Concord Biotech Limited has intimated the stock exchanges about scheduled analyst and institutional investor meetings pursuant to Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Company officials will meet investors/analysts at a group meeting organized by JP Morgan Healthcare Trip on September 23, 2026 at 12:30 pm in Ahmedabad.
The company explicitly states that discussions during these interactions will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) is intended to be discussed.
The disclosure notes that changes to the schedule may occur due to exigencies on the part of the host or the company.